Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

Iris Walraven; Michel M. van den Heuvel; Judi van Diessen; Eva Schaake; Wilma Uyterlinde; Joachim G.J.V. Aerts; Frederieke Koppe; Henk Codrington; Peter W.A. Kunst; Edith Dieleman; Paul van de Vaart; Marcel Verheij; J. Belderbos

doi:10.1016/j.radonc.2016.02.011

JOURNAL ARTICLE

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

Iris Walraven Michel M. van den Heuvel Judi van Diessen Eva Schaake Wilma Uyterlinde Joachim G.J.V. Aerts Frederieke Koppe Henk Codrington Peter W.A. Kunst Edith Dieleman Paul van de Vaart Marcel Verheij J. Belderbos

Year: 2016 Journal: Radiotherapy and Oncology Vol: 118 (3)Pages: 442-446 Publisher: Elsevier BV

DOI: 10.1016/j.radonc.2016.02.011

Get Full-Text PDF Get Analytical Report

Keywords:

Medicine Cetuximab Chemoradiotherapy Regimen Internal medicine Lung cancer Oncology Phases of clinical research Radiation therapy Clinical endpoint Mucositis Chemotherapy Cancer Randomized controlled trial Colorectal cancer

Metrics

Cited By

8.81

FWCI (Field Weighted Citation Impact)

Refs

0.98

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Lung Cancer Diagnosis and Treatment

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

Lung Cancer Treatments and Mutations

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

Lung Cancer Research Studies

Health Sciences → Medicine → Oncology

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

Metrics

Citation History

Topics

Related Documents

Long-term Follow-up Results of Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients

Sequential Chemoradiotherapy with Accelerated Hypofractionated Radiotherapy Compared to Concurrent Chemoradiotherapy with Standard Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Secondary primary cancer in the long-term survivors with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer